Physician profile
William A Mcdade
NPI 1417012634
$11,767.17
in general payments reported to CMS, 2019-2025
6 companies · $122 in 2025
The $122 reported for 2025 was more than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $658 · 2022: $5,225 · 2023: $5,174 · 2024: $589 · 2025: $122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,000 · Travel and Lodging: $505 · Food and Beverage: $380.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,000.00 |
| Travel and Lodging | $504.96 |
| Food and Beverage | $379.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $11,162.84 | 2021-2024 | |
| Medtronic, INC. | $173.85 | 2022-2023 | Mcgrath Mac |
| Viiv Healthcare Company | $121.59 | 2025 | |
| Novo Nordisk INC | $117.15 | 2022 | |
| Gilead Sciences, INC. | $107.97 | 2023 | |
| Acadia Pharmaceuticals INC | $83.77 | 2024 | Nuplazid |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Mcdade listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.